Zobrazeno 1 - 5
of 5
pro vyhledávání: '"tumor-initiating cancer stem cells"'
Autor:
E. A. Potter, E. V. Dolgova, A. M. Minkevich, V. P. Nikolin, N. A. Popova, Ya. R. Efremov, S. I. Baiborodin, V. A. Rogachev, A. S. Proskurina, O. S. Taranov, E. I. Vereschagin, A. A. Ostanin, E. R. Chernykh, N. A. Kolchanov, S. S. Bogachev
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 20, Iss 5, Pp 716-722 (2016)
Previously, we reported on the development of a therapeutic regimen allowing eradication of primary murine Krebs-2 ascites transplants. This protocol involved multiple injections of dsDNA preparations administered during the NER and HR phases of repa
Externí odkaz:
https://doaj.org/article/72e755fdce694cac9febfbc60bf7e694
Autor:
E. A. Potter, E. V. Dolgova, A. M. Minkevich, Ya. R. Efremov, O. S. Taranov, V. V. Omigov, V. P. Nikolin, N. A. Popova, A. S. Proskurina, E. I. Vereschagin, A. V. Kozel, V. A. Rogachev, D. B. Petrov, A. A. Ostanin, E. R. Chernykh, N. A. Kolchanov, S. S. Bogachev
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 20, Iss 1, Pp 96-107 (2016)
Existence of a small subset of cancer cells referred to as tumor initiating stem cells (TISCs) largely responsible for tumor progression and resistance to chemotherapeutic cytostatic drugs reperesent an important recent paradigm shift. The present wo
Externí odkaz:
https://doaj.org/article/286909d4625d482ead65a231e57499c6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vladimir A. Rogachev, S. S. Bogachev, E. V. Dolgova, A. S. Proskurina, Ekaterina A. Potter, Ya. R. Efremov, Valery P. Nikolin, E. I. Vereschagin, Nelly A. Popova, S. I. Baiborodin, Alexandr A. Ostanin, Elena R. Chernykh, O. S. Taranov, A. M. Minkevich, N. A. Kolchanov
Publikováno v:
Vavilovskij Žurnal Genetiki i Selekcii, Vol 20, Iss 5, Pp 716-722 (2016)
Previously, we reported on the development of a therapeutic regimen allowing eradication of primary murine Krebs-2 ascites transplants. This protocol involved multiple injections of dsDNA preparations administered during the NER and HR phases of repa
Autor:
Array С. Богачев, Array А. Колчанов, Array А. Поттер, Array В. Омигов, Array С. Проскурина, Array А. Рогачев, Array П. Николин, Array Р. Черных, Array Р. Ефремов, Array В. Козел, Array В. Долгова, Array А. Останин, Array А. Попова, Array С. Таранов, Array И. Верещагин, Array Б. Петров, Array М. Минкевич
Publikováno v:
Vavilovskij Žurnal Genetiki i Selekcii, Vol 20, Iss 1, Pp 96-107 (2016)
Existence of a small subset of cancer cells referred to as tumor initiating stem cells (TISCs) largely responsible for tumor progression and resistance to chemotherapeutic cytostatic drugs reperesent an important recent paradigm shift. The present wo